Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
S J HorningS A Rosenberg

Abstract

We have demonstrated that a relatively mild chemotherapy regimen, vinblastine, methotrexate, and bleomycin (VBM), and involved-field radiotherapy (IFRT) could substitute for extended-field radiotherapy in patients with favorable Hodgkin's disease (HD) who have been laparotomy-staged. The purpose of this study is to determine if VBM and regional radiotherapy can substitute for extended-field radiotherapy in favorable clinical stage (CS) I and II HD. Seventy-eight patients with favorable CS I to II HD were randomly assigned to subtotal lymphoid irradiation (STLI) or VBM chemotherapy and regional radiotherapy. Randomization was stratified on the basis of age, sex, number of Ann Arbor sites, histology, and institution. Patients were evaluated for freedom from progressive HD, survival, and toxicity. Results were compared with the predecessor trial in pathologically staged patients. With a median follow-up period of 4 years, the rate of freedom from progressive HD was 92% (95% confidence interval [CI], 88% to 96%) for patients treated with STLI and 87% (95% CI, 81% to 93%) for patients treated with VBM and regional radiotherapy. Six of seven patients who relapsed are alive and in remission following successful second-line therapy. Gi...Continue Reading

Citations

Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A K NgK M Kuntz
Jun 27, 2000·Australian and New Zealand Journal of Medicine·A WirthH M Prince
Aug 29, 2003·Current Treatment Options in Oncology·Andreas Josting, Volker Diehl
Jan 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael Zach KoontzRanjana H Advani
Sep 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A GanzRichard I Fisher
Jul 24, 2004·Internal Medicine Journal·S S FooA M Scott
May 15, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M Busch, E Dühmke
Feb 28, 2003·European Journal of Haematology·Daniel MolinUNKNOWN Swedish Lymphoma Study Group
May 2, 2003·European Journal of Nuclear Medicine and Molecular Imaging·K E Kogel, J W Sweetenham
Oct 20, 2005·The Cochrane Database of Systematic Reviews·J G FranklinL Specht
Jul 11, 2013·BioMed Research International·Fan-Lin KongDavid J Yang
Apr 12, 2003·Leukemia & Lymphoma·Mariano ProvencioFélix Bonilla
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A WirthK Liew
Nov 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O W PressR I Fisher
Oct 29, 2004·Upsala Journal of Medical Sciences·Daniel Molin
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E DühmkeV Diehl
Apr 6, 2011·Leukemia & Lymphoma·Lauren S MaedaRanjana H Advani
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea K NgPeter M Mauch
Nov 9, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R H AdvaniS J Horning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.